ATE152128T1 - Verfahren zur herstellung des von willebrand- faktors von höchster reinheit - Google Patents

Verfahren zur herstellung des von willebrand- faktors von höchster reinheit

Info

Publication number
ATE152128T1
ATE152128T1 AT91402124T AT91402124T ATE152128T1 AT E152128 T1 ATE152128 T1 AT E152128T1 AT 91402124 T AT91402124 T AT 91402124T AT 91402124 T AT91402124 T AT 91402124T AT E152128 T1 ATE152128 T1 AT E152128T1
Authority
AT
Austria
Prior art keywords
von willebrand
willebrand factor
factor
producing
highest purity
Prior art date
Application number
AT91402124T
Other languages
English (en)
Inventor
Bernard Dazey
Mohamed Hamsany
Gerard Vezon
Original Assignee
Aquitaine Dev Transf Sanguine
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9399373&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE152128(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Aquitaine Dev Transf Sanguine filed Critical Aquitaine Dev Transf Sanguine
Application granted granted Critical
Publication of ATE152128T1 publication Critical patent/ATE152128T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/755—Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hematology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT91402124T 1990-08-02 1991-07-30 Verfahren zur herstellung des von willebrand- faktors von höchster reinheit ATE152128T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9009917A FR2665449B1 (fr) 1990-08-02 1990-08-02 Procede de fabrication de facteur von willebrand ayant une tres haute purete, depourvu en majeure partie de facteur antihemophilique (fviiic), et facteur von willebrand ainsi obtenu, ainsi qu'une composition pharmaceutique le contenant.

Publications (1)

Publication Number Publication Date
ATE152128T1 true ATE152128T1 (de) 1997-05-15

Family

ID=9399373

Family Applications (1)

Application Number Title Priority Date Filing Date
AT91402124T ATE152128T1 (de) 1990-08-02 1991-07-30 Verfahren zur herstellung des von willebrand- faktors von höchster reinheit

Country Status (9)

Country Link
US (1) US5252710A (de)
EP (1) EP0469985B1 (de)
JP (1) JP2559645B2 (de)
AT (1) ATE152128T1 (de)
DE (2) DE469985T1 (de)
DK (1) DK0469985T3 (de)
ES (1) ES2038095T3 (de)
FR (1) FR2665449B1 (de)
GR (1) GR3024115T3 (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5760183A (en) * 1989-02-17 1998-06-02 Association D'aquitaine Pour De Developpment De La Transfusion Sanguine Et Des Recherches Hematologiques Process for the manufacture of very high-purity antithaemophilic factor (FVIIIC), and von Willebrand factor, and pharmaceutical compositions containing same
US5629287A (en) * 1991-01-18 1997-05-13 University College London Depot formulations
US5610148A (en) * 1991-01-18 1997-03-11 University College London Macroscopically oriented cell adhesion protein for wound treatment
DE4435392B4 (de) * 1994-10-04 2008-02-07 Immuno Ag Verfahren zur Trennung von vWF in hochmolekularen vWF und niedermolekularen vWF
DE4435485C1 (de) * 1994-10-04 1996-03-21 Immuno Ag Verfahren zur Gewinnung von hochreinem von Willebrand-Faktor
US5659017A (en) * 1995-11-07 1997-08-19 Alpha Therapeutic Corporation Anion exchange process for the purification of Factor VIII
US6005077A (en) * 1995-11-10 1999-12-21 Immuno Aktiengesellschaft Use of von willebrand factor and pharmaceutical formulation
KR970060724A (ko) * 1996-01-16 1997-08-12 김광호 백업용 배터리 동작의 표시방법 및 그 감지회로
AT405403B (de) * 1997-02-27 1999-08-25 Immuno Ag Reinigung von von willebrand-faktor durch kationenaustauscherchromatographie
AT406867B (de) 1997-02-27 2000-10-25 Immuno Ag Verfahren zur gewinnung von hochreinem vwf oder faktor viii/vwf-komplex
US6531577B1 (en) * 1997-12-15 2003-03-11 Hemasure Denmark A/S von Willebrand factor (vWF)-containing preparation, process for preparing vWF-containing preparations, and use of such preparations
DK1820516T3 (da) 1999-02-22 2013-10-28 Univ Connecticut Nye albuminfrie faktor VIII-præparater
EP1240900B1 (de) * 1999-12-24 2009-05-06 Juridical Foundation, The Chemo-Sero-Therapeutic Research Institute Faktor viii oder von willebrand faktor zur behandlung von thrombopathie assoziierenden hämorrhagischen erkrankungen
JP4663837B2 (ja) * 1999-12-24 2011-04-06 一般財団法人化学及血清療法研究所 第▲ｖｉｉｉ▼因子を主成分とする血小板減少に伴う出血疾患の予防・治療用医薬組成物
ATE460451T1 (de) * 2003-07-22 2010-03-15 Nektar Therapeutics Verfahren zur herstellung von funktionalisierten polymeren aus polymeralkoholen
FR2874216B1 (fr) * 2004-08-16 2006-11-03 Lab Francais Du Fractionnement Procede de preparation d'un concentre de facteur von willebrand (fvw) par voie chromatographique et concentre de fvw susceptible d'etre ainsi obtenu
US8568705B2 (en) * 2005-07-18 2013-10-29 Nektar Therapeutics Method for preparing branched functionalized polymers using branched polyol cores
EP2297330A4 (de) * 2008-06-04 2012-03-14 Bayer Healthcare Llc Fvii-muteine zur behandlung von morbus willebrand
MX339060B (es) 2008-11-07 2016-05-09 Baxter Int Formulaciones del factor viii.
IT1396528B1 (it) 2009-01-19 2012-12-14 Kedrion Spa Nuovo processo di purificazione altamente selettivo di due proteine plasmatiche: von willebrand factor (vwf) e fibronectina (fn).

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4170590A (en) * 1974-12-14 1979-10-09 Biotest-Serum-Institut Gmbh Ion exchanger treatment of citrate-stabilized plasma
US4508709A (en) * 1983-12-05 1985-04-02 Armour Pharmaceutical Company Process for purifying factor VIII:C
FR2570276B1 (fr) * 1984-09-18 1987-09-04 Immunotech Sa Procede d'obtention du complexe fviii/vwf a usage therapeutique et produits en resultant
JPS63108000A (ja) * 1986-05-15 1988-05-12 Green Cross Corp:The 第８因子の精製方法
US4774323A (en) * 1987-06-29 1988-09-27 Rorer Pharmaceutical Corporation Purification of von Willebrand Factor solutions using gel permeation chromatography
NL8701915A (nl) * 1987-08-14 1989-03-01 Waander Riethorst Adsorbensmateriaal en toepassing daarvan voor het isoleren van stollingsfaktoren.
FR2632309B1 (fr) * 1988-06-07 1990-08-24 Lille Transfusion Sanguine Procede de purification par voie chromatographique de proteines, notamment de facteur viii, et les produits obtenus
FR2644064B1 (fr) * 1989-02-17 1994-05-27 Aquitaine Dev Transf Sanguine Procede de fabrication du facteur antihemophilique fviiic ayant une tres haute purete et facteur antihemophilique fviiic ainsi obtenu, ainsi que composition pharmaceutique le contenant
FR2650393A1 (fr) * 1989-07-28 1991-02-01 Herault Ctre Rgl Transfusion S Methode de purification du facteur vii (f viii) par chromatographie echangeuse d'ions

Also Published As

Publication number Publication date
ES2038095T3 (es) 1997-09-16
DE69125764T2 (de) 1997-11-13
DK0469985T3 (da) 1997-10-20
DE469985T1 (de) 1992-10-15
FR2665449A1 (fr) 1992-02-07
ES2038095T1 (es) 1993-07-16
JP2559645B2 (ja) 1996-12-04
FR2665449B1 (fr) 1995-04-14
GR3024115T3 (en) 1997-10-31
DE69125764D1 (de) 1997-05-28
US5252710A (en) 1993-10-12
EP0469985B1 (de) 1997-04-23
EP0469985A1 (de) 1992-02-05
JPH04234400A (ja) 1992-08-24

Similar Documents

Publication Publication Date Title
ATE152128T1 (de) Verfahren zur herstellung des von willebrand- faktors von höchster reinheit
UA11061A (uk) Спосіб розділеhhя білків крові
DE69106100D1 (de) Verfahren zur Trennung durch Adsorption und Adsorber.
LV10053A (lv) Kompleksa "Faktors-YIII + fon Villebranda faktors" koncentrata iegusanas metode
ITFI920078A1 (it) Processo per l'isolamento di fattore ix, fattore x e fattore ii altamente purificati dal complesso protrombinico o dal plasma umano
ATE128950T1 (de) Verfahren zur reinigung von wasserstoffperoxyd für die mikroelektronik.
ATE91152T1 (de) Gereinigte protein a-zusammensetzungen und verfahren zu ihrer herstellung.
DK0646594T3 (da) Fremgangsmåde til rensning af proteiner
DE69307701D1 (de) Verfahren zur reinigung von acetonitril
HU9301038D0 (en) Method for producing virus-safe vii factor of high purity
ATE347564T1 (de) Verfahren zur reinigung von hämoglobin
ATE388722T1 (de) THERAPEUTISCHE FRAGMENTE DES ßVON WILLEBRANDß FAKTORS
ES2042027T3 (es) Procedimiento de recuperacion de acido citrico a partir de un licor que lo contiene.
DE69029471D1 (de) Wiedergewinnungsverfahren von mikrobiell erzeugtem chymosin
DE69406803D1 (de) Adsorptionsseparationsprozess mit mehrstufigem spülen
DE69902639D1 (de) Verbessertes verfahren zur herstellung von faktor viii
JPS6487685A (en) Production of liquid crystal composition of high resistivity
GR930300095T1 (en) Process for preparing highly purified fibrinogen
DE69620539D1 (de) Verfahren zur Reinigung von Thrombomodulin
DK0383645T3 (da) Fremgangsmåde til fremstilling af antihæmofilifaktor (FVIIIc) med meget høj renhed
DE59507012D1 (de) Verfahren zur Herstellung von Adsorptionsmittelgranulaten
KR940013535A (ko) 순수한 인 혈액 응고 제2인자 및 제9인자의 정제 방법
PL265427A1 (en) Method of purifying gaseous mixtures by adsorption processes and adsorber therefor
NZ326494A (en) Production of an immunoglobulin enriched fraction from whey protein solutions using a cation exchanger
JPS6486871A (en) Method for separating and purifying recombinant protein

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee